应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
02137 腾盛博药-B
已收盘 01-09 16:08:33
1.520
+0.000
0.00%
最高
1.550
最低
1.500
成交量
61.80万
今开
1.510
昨收
1.520
日振幅
3.29%
总市值
10.96亿
流通市值
10.96亿
总股本
7.21亿
成交额
94.03万
换手率
0.09%
流通股本
7.21亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
腾盛博药-B01月07日主力净流入16.6万元 散户资金抛售
市场透视 · 01-07 16:15
腾盛博药-B01月07日主力净流入16.6万元 散户资金抛售
腾盛博药(02137)更新12月股份变动月报表,股本小幅增加50,352股
公告速递 · 01-06 16:47
腾盛博药(02137)更新12月股份变动月报表,股本小幅增加50,352股
AI 制药合作潮下,药物研发已进入“深水区
制药网 · 2025-12-31
AI 制药合作潮下,药物研发已进入“深水区
腾盛博药-B12月29日遭主力抛售132.2万元
市场透视 · 2025-12-29
腾盛博药-B12月29日遭主力抛售132.2万元
腾盛博药-B12月23日遭主力抛售70.0万元
市场透视 · 2025-12-23
腾盛博药-B12月23日遭主力抛售70.0万元
腾盛博药-B12月18日主力净流出73.0万元 散户资金买入
市场透视 · 2025-12-18
腾盛博药-B12月18日主力净流出73.0万元 散户资金买入
腾盛博药-B12月16日遭主力抛售56.3万元
市场透视 · 2025-12-16
腾盛博药-B12月16日遭主力抛售56.3万元
腾盛博药-B12月15日遭主力抛售24.1万元
市场透视 · 2025-12-15
腾盛博药-B12月15日遭主力抛售24.1万元
Openbench - 将因提供符合Brii Bio定义的特定标准的新潜在客户而获得付款
美股速递 · 2025-12-11
Openbench - 将因提供符合Brii Bio定义的特定标准的新潜在客户而获得付款
腾盛博药-B12月05日主力净流出91.8万元 散户资金买入
市场透视 · 2025-12-05
腾盛博药-B12月05日主力净流出91.8万元 散户资金买入
腾盛博药(02137)公布2025年11月月报,合计新增190,125股
公告速递 · 2025-12-03
腾盛博药(02137)公布2025年11月月报,合计新增190,125股
腾盛博药-B12月02日主力净流出93.1万元 散户资金买入
市场透视 · 2025-12-02
腾盛博药-B12月02日主力净流出93.1万元 散户资金买入
腾盛博药-B11月27日主力净流入90.2万元 散户资金抛售
市场透视 · 2025-11-27
腾盛博药-B11月27日主力净流入90.2万元 散户资金抛售
腾盛博药-B盘中异动 急速拉升5.45%
市场透视 · 2025-11-25
腾盛博药-B盘中异动 急速拉升5.45%
腾盛博药-B11月21日主力净流出64.8万元 散户资金买入
市场透视 · 2025-11-21
腾盛博药-B11月21日主力净流出64.8万元 散户资金买入
腾盛博药-B盘中异动 股价大跌5.23%
市场透视 · 2025-11-21
腾盛博药-B盘中异动 股价大跌5.23%
腾盛博药-B11月18日遭主力抛售81.5万元
市场透视 · 2025-11-18
腾盛博药-B11月18日遭主力抛售81.5万元
腾盛博药-B11月17日遭主力抛售130.1万元
市场透视 · 2025-11-17
腾盛博药-B11月17日遭主力抛售130.1万元
腾盛博药-B11月14日主力净流出159.7万元 散户资金买入
市场透视 · 2025-11-14
腾盛博药-B11月14日主力净流出159.7万元 散户资金买入
腾盛博药-B(02137)在2025年AASLD大会上发布ENSURE II期研究最新突破性数据
智通财经 · 2025-11-10
腾盛博药-B(02137)在2025年AASLD大会上发布ENSURE II期研究最新突破性数据
加载更多
公司概况
公司名称:
腾盛博药-B
所属市场:
SEHK
上市日期:
--
主营业务:
腾盛博药生物科技有限公司是一家主要专注于开发感染性疾病及中枢神经系统疾病治疗方案的生物技术公司。该公司的HBV产品组合包括专有的治疗性疫苗BRII-179、the siRNA BRII-835 (elebsiran),及中和抗体BRII-877 (tobevibart). 该公司拥有多种创新候选药物的产品线,专注于治疗传染病和中枢神经系统疾病。该公司的产品应用于传染病(如乙型肝炎病毒(HBV)、人类免疫缺陷病毒(HIV)、多重耐药(MDR)或广泛耐药性(XDR)革兰氏阴性菌感染)及其他疾病(如中枢神经系统(CNS)疾病)。该公司主要在中国国内市场开展业务。
发行价格:
--
{"stockData":{"symbol":"02137","market":"HK","secType":"STK","nameCN":"腾盛博药-B","latestPrice":1.52,"timestamp":1767946113487,"preClose":1.52,"halted":0,"volume":618000,"delay":0,"floatShares":721000000,"shares":721000000,"eps":-0.776958685213189,"marketStatus":"已收盘","change":0,"latestTime":"01-09 16:08:33","open":1.51,"high":1.55,"low":1.5,"amount":940250,"amplitude":0.032895,"askPrice":1.55,"askSize":26500,"bidPrice":1.52,"bidSize":63000,"shortable":0,"etf":0,"ttmEps":-0.5768542278431679,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1768181400000},"marketStatusCode":5,"adr":0,"listingDate":1626105600000,"exchange":"SEHK","adjPreClose":1.52,"openAndCloseTimeList":[[1767922200000,1767931200000],[1767934800000,1767945600000]],"volumeRatio":0.572434,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02137","defaultTab":"news","newsList":[{"id":"2601384708","title":"腾盛博药-B01月07日主力净流入16.6万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2601384708","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601384708?lang=zh_cn&edition=full","pubTime":"2026-01-07 16:15","pubTimestamp":1767773727,"startTime":"0","endTime":"0","summary":"01月07日, 腾盛博药-B股价涨4.70%,报收1.56元,成交金额127.7万元,换手率0.12%,振幅4.70%,量比0.63。腾盛博药-B今日主力资金净流入16.6万元,上一交易日主力净流出0万元。该股近5个交易日上涨9.15%,主力资金累计净流出25.3万元;近20日主力资金累计净流出723.2万元,其中净流出天数为13日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260107161718a4a6d078&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260107161718a4a6d078&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1587","BK1574","02137"],"gpt_icon":0},{"id":"1199159672","title":"腾盛博药(02137)更新12月股份变动月报表,股本小幅增加50,352股","url":"https://stock-news.laohu8.com/highlight/detail?id=1199159672","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1199159672?lang=zh_cn&edition=full","pubTime":"2026-01-06 16:47","pubTimestamp":1767689270,"startTime":"0","endTime":"0","summary":"腾盛博药生物科技有限公司于2026年1月6日发布截至2025年12月31日的月度股份变动报告。公告显示,公司法定/注册股本保持在1,200,000,000股,面值每股USD 0.000005,注册股本总额仍为USD 6,000,未见变动。公司本月主要新增发行来源包括期权计划行使41,875股,以及根据首次公开发售后股份奖励计划授出8,477股,未见购回或注销记录。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02137"],"gpt_icon":0},{"id":"2595747786","title":"AI 制药合作潮下,药物研发已进入“深水区","url":"https://stock-news.laohu8.com/highlight/detail?id=2595747786","media":"制药网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595747786?lang=zh_cn&edition=full","pubTime":"2025-12-31 11:21","pubTimestamp":1767151265,"startTime":"0","endTime":"0","summary":"值得注意的是,基于此,AI+制药领域的合作开始不断增多,研发领域也开始从小分子药物向多肽药物和双特异性抗体等拓展。如12月11日,腾盛博药宣布与OpenBench达成合作,将利用OpenBench的结构驱动人工智能平台,加速腾盛博药在创新药物发现领域的研发进程,并推动其专有技术平台的应用。12月9日,甘李药业宣布与晶泰控股达成代谢疾病领域AI多肽创新药的研发合作及AI技术平台使用授权协议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251231112307a6e3b8d7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251231112307a6e3b8d7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["03696","01477","02137","BK1574","BK1191"],"gpt_icon":1},{"id":"2595324717","title":"腾盛博药-B12月29日遭主力抛售132.2万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2595324717","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595324717?lang=zh_cn&edition=full","pubTime":"2025-12-29 16:16","pubTimestamp":1766996168,"startTime":"0","endTime":"0","summary":"12月29日, 腾盛博药-B股价跌0.69%,报收1.44元,成交金额324.2万元,换手率0.31%,振幅2.76%,量比1.37。腾盛博药-B今日主力资金净流出132.2万元,连续5日净流出,上一交易日主力净流出70.0万元。该股近5个交易日下跌2.04%,主力资金累计净流出346.4万元,其中1个交易日为股价上涨时净流出;近20日主力资金累计净流出643.1万元,其中净流出天数为13日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251229162355a6dc3c54&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251229162355a6dc3c54&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","BK1161","BK1587","02137"],"gpt_icon":0},{"id":"2593448378","title":"腾盛博药-B12月23日遭主力抛售70.0万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2593448378","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593448378?lang=zh_cn&edition=full","pubTime":"2025-12-23 16:16","pubTimestamp":1766477764,"startTime":"0","endTime":"0","summary":"12月23日, 腾盛博药-B股价跌0.67%,报收1.49元,成交金额191.2万元,换手率0.18%,振幅4.67%,量比0.80。腾盛博药-B今日主力资金净流出70.0万元,连续4日净流出,上一交易日主力净流出15.5万元。该股近5个交易日上涨0.68%,主力资金累计净流出214.2万元;近20日主力资金累计净流出511.0万元,其中净流出天数为12日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251223162256a46e0a11&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251223162256a46e0a11&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1587","BK1161","BK1574","02137"],"gpt_icon":0},{"id":"2592974590","title":"腾盛博药-B12月18日主力净流出73.0万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2592974590","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592974590?lang=zh_cn&edition=full","pubTime":"2025-12-18 16:15","pubTimestamp":1766045745,"startTime":"0","endTime":"0","summary":"12月18日, 腾盛博药-B股价跌2.00%,报收1.47元,成交金额368.6万元,换手率0.35%,振幅3.33%,量比1.86。腾盛博药-B今日主力资金净流出73.0万元,上一交易日主力净流出0万元。该股近5个交易日下跌5.77%,主力资金累计净流出172.2万元,其中1个交易日为股价上涨时净流出;近20日主力资金累计净流出405.3万元,其中净流出天数为10日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251218161930a6b1a073&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251218161930a6b1a073&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1587","BK1161","02137","BK1574"],"gpt_icon":0},{"id":"2592193192","title":"腾盛博药-B12月16日遭主力抛售56.3万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2592193192","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592193192?lang=zh_cn&edition=full","pubTime":"2025-12-16 16:16","pubTimestamp":1765872963,"startTime":"0","endTime":"0","summary":"12月16日, 腾盛博药-B股价跌3.90%,报收1.48元,成交金额288.9万元,换手率0.27%,振幅4.55%,量比1.39。腾盛博药-B今日主力资金净流出56.3万元,连续4日净流出,上一交易日主力净流出24.1万元。该股近5个交易日下跌6.33%,主力资金累计净流出130.2万元,其中1个交易日为股价上涨时净流出;近20日主力资金累计净流出332.3万元,其中净流出天数为9日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251216162319a4519210&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251216162319a4519210&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1574","BK1587","02137"],"gpt_icon":0},{"id":"2591660839","title":"腾盛博药-B12月15日遭主力抛售24.1万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2591660839","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591660839?lang=zh_cn&edition=full","pubTime":"2025-12-15 16:15","pubTimestamp":1765786549,"startTime":"0","endTime":"0","summary":"12月15日, 腾盛博药-B股价跌1.91%,报收1.54元,成交金额314.0万元,换手率0.29%,振幅5.73%,量比1.78。腾盛博药-B今日主力资金净流出24.1万元,连续3日净流出,上一交易日主力净流出18.7万元。该股近5个交易日下跌6.10%,主力资金累计净流出203.5万元,其中1个交易日为股价上涨时净流出;近20日主力资金累计净流出357.5万元,其中净流出天数为9日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251215162023a44d2fd1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251215162023a44d2fd1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1587","BK1574","BK1161","02137"],"gpt_icon":0},{"id":"1124379607","title":"Openbench - 将因提供符合Brii Bio定义的特定标准的新潜在客户而获得付款","url":"https://stock-news.laohu8.com/highlight/detail?id=1124379607","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1124379607?lang=zh_cn&edition=full","pubTime":"2025-12-11 20:36","pubTimestamp":1765456599,"startTime":"0","endTime":"0","summary":"Openbench - 将因提供符合Brii Bio定义的特定标准的新潜在客户而获得付款","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02137","BK1574","BK1161","BK1587"],"gpt_icon":0},{"id":"2589810070","title":"腾盛博药-B12月05日主力净流出91.8万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2589810070","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589810070?lang=zh_cn&edition=full","pubTime":"2025-12-05 16:15","pubTimestamp":1764922551,"startTime":"0","endTime":"0","summary":"12月05日, 腾盛博药-B股价跌1.84%,报收1.60元,成交金额312.0万元,换手率0.27%,振幅3.07%,量比1.61。腾盛博药-B今日主力资金净流出91.8万元,上一交易日主力净流出0万元。该股近5个交易日下跌8.62%,主力资金累计净流出201.6万元;近20日主力资金累计净流出508.7万元,其中净流出天数为8日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251205162040979179ad&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251205162040979179ad&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02137","BK1574","BK1587","BK1161"],"gpt_icon":0},{"id":"1106824396","title":"腾盛博药(02137)公布2025年11月月报,合计新增190,125股","url":"https://stock-news.laohu8.com/highlight/detail?id=1106824396","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1106824396?lang=zh_cn&edition=full","pubTime":"2025-12-03 16:36","pubTimestamp":1764750981,"startTime":"0","endTime":"0","summary":"腾盛博药生物科技有限公司于2025年12月3日发布2025年11月股份变动月报。公告显示,公司本月并无调整法定股本,维持面值为每股0.000005美元、注册股本合计6,000美元不变。公司期权与股权激励计划方面,2023年购股权计划本月行使114,500股,共为公司带来资金121,599港元;另外,首次公开发售后股份奖励计划及2023年股份奖励计划合计新增75,625股。上述多项变动累计令公司已发行股数当月净增190,125股。截至2025年11月30日,公司股本较上月略有上升。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02137"],"gpt_icon":0},{"id":"2588406887","title":"腾盛博药-B12月02日主力净流出93.1万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2588406887","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588406887?lang=zh_cn&edition=full","pubTime":"2025-12-02 16:15","pubTimestamp":1764663348,"startTime":"0","endTime":"0","summary":"12月02日, 腾盛博药-B股价跌1.16%,报收1.70元,成交金额346.2万元,换手率0.28%,振幅2.91%,量比2.10。腾盛博药-B今日主力资金净流出93.1万元,上一交易日主力净流出0万元。该股近5个交易日下跌0.58%,主力资金累计净流入71.5万元;近20日主力资金累计净流出439.9万元,其中净流出天数为7日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202512021620219526518b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202512021620219526518b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1587","02137","BK1574"],"gpt_icon":0},{"id":"2586827616","title":"腾盛博药-B11月27日主力净流入90.2万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2586827616","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586827616?lang=zh_cn&edition=full","pubTime":"2025-11-27 16:15","pubTimestamp":1764231358,"startTime":"0","endTime":"0","summary":"11月27日, 腾盛博药-B股价涨2.34%,报收1.75元,成交金额241.1万元,换手率0.19%,振幅3.51%,量比0.87。腾盛博药-B今日主力资金净流入90.2万元,上一交易日主力净流出0万元。该股近5个交易日上涨1.74%,主力资金累计净流入54.6万元;近20日主力资金累计净流出499.2万元,其中净流出天数为7日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025112716222797825d24&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025112716222797825d24&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02137","BK1587","BK1574","BK1161"],"gpt_icon":0},{"id":"2586342726","title":"腾盛博药-B盘中异动 急速拉升5.45%","url":"https://stock-news.laohu8.com/highlight/detail?id=2586342726","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586342726?lang=zh_cn&edition=full","pubTime":"2025-11-25 10:45","pubTimestamp":1764038721,"startTime":"0","endTime":"0","summary":"2025年11月25日早盘10时45分,腾盛博药-B股票出现异动,股价快速拉升5.45%。截至发稿,该股报1.740港元/股,成交量73.05万股,换手率0.10%,振幅3.64%。腾盛博药-B股票所在的生物技术行业中,整体涨幅为1.44%。腾盛博药-B公司简介:腾盛博药生物科技有限公司是一家主要从事感染性疾病以及中枢神经系统疾病治疗方法开发的生物科技公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251125104522a70f854e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251125104522a70f854e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1587","02137","BK1161","BK1574"],"gpt_icon":0},{"id":"2585142749","title":"腾盛博药-B11月21日主力净流出64.8万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2585142749","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585142749?lang=zh_cn&edition=full","pubTime":"2025-11-21 16:15","pubTimestamp":1763712959,"startTime":"0","endTime":"0","summary":"11月21日, 腾盛博药-B股价跌6.40%,报收1.61元,成交金额631.8万元,换手率0.54%,振幅5.81%,量比1.68。腾盛博药-B今日主力资金净流出64.8万元,上一交易日主力净流出0万元。该股近5个交易日下跌11.54%,主力资金累计净流出276.4万元;近20日主力资金累计净流出658.2万元,其中净流出天数为9日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202511211622179777456b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202511211622179777456b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","BK1587","BK1161","02137"],"gpt_icon":0},{"id":"2585114272","title":"腾盛博药-B盘中异动 股价大跌5.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2585114272","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585114272?lang=zh_cn&edition=full","pubTime":"2025-11-21 10:33","pubTimestamp":1763692388,"startTime":"0","endTime":"0","summary":"2025年11月21日早盘10时33分,腾盛博药-B股票出现异动,股价快速下跌5.23%。截至发稿,该股报1.630港元/股,成交量126.228万股,换手率0.18%,振幅3.49%。腾盛博药-B股票所在的生物技术行业中,整体跌幅为4.56%。腾盛博药-B公司简介:腾盛博药生物科技有限公司是一家主要从事感染性疾病以及中枢神经系统疾病治疗方法开发的生物科技公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202511211033089776b37c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202511211033089776b37c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1587","02137","BK1161","BK1574"],"gpt_icon":0},{"id":"2584937632","title":"腾盛博药-B11月18日遭主力抛售81.5万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2584937632","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584937632?lang=zh_cn&edition=full","pubTime":"2025-11-18 16:15","pubTimestamp":1763453745,"startTime":"0","endTime":"0","summary":"11月18日, 腾盛博药-B股价跌1.70%,报收1.73元,成交金额350.8万元,换手率0.28%,振幅3.41%,量比0.81。腾盛博药-B今日主力资金净流出81.5万元,连续3日净流出,上一交易日主力净流出130.1万元。该股近5个交易日下跌5.98%,主力资金累计净流出371.3万元;近20日主力资金累计净流出990.3万元,其中净流出天数为11日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202511181620179770b484&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202511181620179770b484&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","BK1161","02137","BK1587"],"gpt_icon":0},{"id":"2584564333","title":"腾盛博药-B11月17日遭主力抛售130.1万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2584564333","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584564333?lang=zh_cn&edition=full","pubTime":"2025-11-17 16:15","pubTimestamp":1763367310,"startTime":"0","endTime":"0","summary":"11月17日, 腾盛博药-B股价跌3.30%,报收1.76元,成交金额743.0万元,换手率0.58%,振幅4.95%,量比2.10。腾盛博药-B今日主力资金净流出130.1万元,上一交易日主力净流出159.7万元。该股近5个交易日下跌3.30%,主力资金累计净流出354.6万元,其中1个交易日为股价上涨时净流出;近20日主力资金累计净流出1059.2万元,其中净流出天数为11日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251117161535a6fed993&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251117161535a6fed993&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02137","BK1161","BK1574","BK1587"],"gpt_icon":0},{"id":"2583509666","title":"腾盛博药-B11月14日主力净流出159.7万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2583509666","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2583509666?lang=zh_cn&edition=full","pubTime":"2025-11-14 16:15","pubTimestamp":1763108136,"startTime":"0","endTime":"0","summary":"11月14日, 腾盛博药-B股价跌2.67%,报收1.82元,成交金额607.6万元,换手率0.46%,振幅4.28%,量比1.85。腾盛博药-B今日主力资金净流出159.7万元,上一交易日主力净流出0万元。该股近5个交易日上涨0.55%,主力资金累计净流出224.6万元;近20日主力资金累计净流出1053.3万元,其中净流出天数为11日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251114161831a6f8feee&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251114161831a6f8feee&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02137","BK1587","BK1574","BK1161"],"gpt_icon":0},{"id":"2582874386","title":"腾盛博药-B(02137)在2025年AASLD大会上发布ENSURE II期研究最新突破性数据","url":"https://stock-news.laohu8.com/highlight/detail?id=2582874386","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582874386?lang=zh_cn&edition=full","pubTime":"2025-11-10 21:35","pubTimestamp":1762781701,"startTime":"0","endTime":"0","summary":"智通财经APP讯,腾盛博药-B 公布,公司正在进行的ENSURE II期研究队列4治疗结束后24周的随访结果。据悉,ENSURE 是一项在亚太地区开展的多中心、开放标签II期研究。为进一步明确BRII-179在HBV感染治疗中的作用并优化关键性研究的联合疗法,公司正在开展两项额外的IIb期研究。两项研究均已完成患者招募,预计将在2026年公布EOT数据。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1367488.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"腾盛博药-B(02137)在2025年AASLD大会上发布ENSURE II期研究最新突破性数据","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1587","02137","BK1161","BK1574"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.briibio.com","stockEarnings":[{"period":"1week","weight":0.078},{"period":"1month","weight":-0.038},{"period":"3month","weight":-0.2475},{"period":"6month","weight":-0.1648},{"period":"1year","weight":0.4206},{"period":"ytd","weight":0.078}],"compareEarnings":[{"period":"1week","weight":0.0202},{"period":"1month","weight":0.0281},{"period":"3month","weight":-0.0054},{"period":"6month","weight":0.0833},{"period":"1year","weight":0.3563},{"period":"ytd","weight":0.0202}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"腾盛博药生物科技有限公司是一家主要专注于开发感染性疾病及中枢神经系统疾病治疗方案的生物技术公司。该公司的HBV产品组合包括专有的治疗性疫苗BRII-179、the siRNA BRII-835 (elebsiran),及中和抗体BRII-877 (tobevibart). 该公司拥有多种创新候选药物的产品线,专注于治疗传染病和中枢神经系统疾病。该公司的产品应用于传染病(如乙型肝炎病毒(HBV)、人类免疫缺陷病毒(HIV)、多重耐药(MDR)或广泛耐药性(XDR)革兰氏阴性菌感染)及其他疾病(如中枢神经系统(CNS)疾病)。该公司主要在中国国内市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.6,"avgChangeRate":-0.039276},{"month":2,"riseRate":0.5,"avgChangeRate":0.053469},{"month":3,"riseRate":0.25,"avgChangeRate":-0.171794},{"month":4,"riseRate":0.25,"avgChangeRate":-0.017909},{"month":5,"riseRate":0,"avgChangeRate":-0.064507},{"month":6,"riseRate":0.25,"avgChangeRate":-0.093488},{"month":7,"riseRate":1,"avgChangeRate":0.097158},{"month":8,"riseRate":0.2,"avgChangeRate":0.004254},{"month":9,"riseRate":0.6,"avgChangeRate":-0.00155},{"month":10,"riseRate":0.2,"avgChangeRate":-0.127852},{"month":11,"riseRate":0.6,"avgChangeRate":0.286305},{"month":12,"riseRate":0.2,"avgChangeRate":-0.154392}],"exchange":"SEHK","name":"腾盛博药-B","nameEN":"BRII-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"腾盛博药-B(02137)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供腾盛博药-B(02137)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"腾盛博药-B,02137,腾盛博药-B股票,腾盛博药-B股票老虎,腾盛博药-B股票老虎国际,腾盛博药-B行情,腾盛博药-B股票行情,腾盛博药-B股价,腾盛博药-B股市,腾盛博药-B股票价格,腾盛博药-B股票交易,腾盛博药-B股票购买,腾盛博药-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"腾盛博药-B(02137)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供腾盛博药-B(02137)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}